Research ArticleArticle
Characterization of (S)-Des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a Selective High-Affinity Radioligand for 5-Hydroxytryptamine3 Receptors
William A. Hewlett, Bakula L. Trivedi, Zhang-Jin Zhang, Tomas de Paulis, Dennis E. Schmidt, David M. Lovinger, M. Sib Ansari and Michael H. Ebert
Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 221-231;
William A. Hewlett
Bakula L. Trivedi
Zhang-Jin Zhang
Tomas de Paulis
Dennis E. Schmidt
David M. Lovinger
M. Sib Ansari
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 288, Issue 1
1 Jan 1999
Research ArticleArticle
Characterization of (S)-Des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a Selective High-Affinity Radioligand for 5-Hydroxytryptamine3 Receptors
William A. Hewlett, Bakula L. Trivedi, Zhang-Jin Zhang, Tomas de Paulis, Dennis E. Schmidt, David M. Lovinger, M. Sib Ansari and Michael H. Ebert
Journal of Pharmacology and Experimental Therapeutics January 1, 1999, 288 (1) 221-231;
Research ArticleArticle
Characterization of (S)-Des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a Selective High-Affinity Radioligand for 5-Hydroxytryptamine3 Receptors
William A. Hewlett, Bakula L. Trivedi, Zhang-Jin Zhang, Tomas de Paulis, Dennis E. Schmidt, David M. Lovinger, M. Sib Ansari and Michael H. Ebert
Journal of Pharmacology and Experimental Therapeutics January 1, 1999, 288 (1) 221-231;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement